Does Tricare Cover Zepbound? Insurance Guide 2026

Bold opening: Zepbound (tirzepatide) has emerged as a groundbreaking medication for diabetes management and chronic weight loss, but navigating insurance coverage can be complex. For Tricare beneficiaries, understanding whether Zepbound is covered—and under what conditions—is critical for accessing this innovative treatment. This guide explores Tricare’s policies on Zepbound, including eligibility, costs, and steps to secure coverage in 2026.

Does Tricare Cover Zepbound for Diabetes?

Tricare’s coverage of Zepbound for diabetes management depends on clinical necessity and alignment with its formulary policies. As of 2026, Zepbound—a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist—is approved by the FDA for improving glycemic control in adults with type 2 diabetes. Tricare typically covers FDA-approved medications for diabetes when they are deemed medically necessary, but Zepbound may not be listed as a first-line therapy.

To qualify for coverage, beneficiaries must demonstrate that other diabetes medications (e.g., metformin, sulfonylureas, or other GLP-1 agonists like Ozempic) have failed to achieve target HbA1c levels. A prior authorization request, supported by lab results and a physician’s detailed rationale, is often required. Tricare may also require documentation of lifestyle interventions, such as diet and exercise, before approving Zepbound. Given its higher cost compared to older diabetes drugs, Tricare may limit coverage to patients with poorly controlled diabetes or those at high risk of complications.

Does Tricare Cover Zepbound for Weight Loss?

Tricare’s coverage of Zepbound for weight loss is more restrictive than its diabetes indications. Zepbound received FDA approval in 2023 for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity, such as hypertension or sleep apnea. However, Tricare’s weight-loss medication policies are stringent, often prioritizing lifestyle modifications and bariatric surgery over pharmacotherapy.

As of 2026, Tricare may cover Zepbound for weight loss only under specific conditions: beneficiaries must have a documented history of failed weight-loss attempts through diet, exercise, and behavioral therapy, and they must meet BMI criteria. Prior authorization is mandatory, and coverage is typically limited to a 12- to 24-month trial period. Tricare may also require participation in a supervised weight-loss program as a condition for approval. Given these restrictions, many beneficiaries may find it challenging to secure coverage for Zepbound solely for weight loss, though exceptions exist for those with severe obesity-related health risks.

How Much Does Zepbound Cost With Tricare?

The out-of-pocket cost of Zepbound with Tricare varies based on the beneficiary’s plan, formulary tier, and pharmacy network. Without insurance, Zepbound can cost upwards of $1,000 per month, but Tricare’s coverage significantly reduces this expense. For most beneficiaries, Zepbound falls under Tricare’s Tier 3 or Tier 4 formulary, meaning copays range from $20 to $60 per month for a 30-day supply, depending on whether the medication is generic or brand-name.

Active-duty service members and their families under Tricare Prime may pay little to no copay, while Tricare Select beneficiaries could face higher costs. Additionally, Tricare’s catastrophic cap limits annual out-of-pocket expenses, providing financial protection for those requiring long-term Zepbound therapy. Beneficiaries should verify their specific copay through the Tricare Pharmacy Program or their regional contractor, as costs may differ for retail pharmacies versus mail-order services. For those without prior authorization, Zepbound may not be covered, leading to full retail pricing.

Zepbound Prior Authorization for Tricare

Securing Zepbound coverage through Tricare requires a prior authorization (PA), a process that ensures the medication is medically necessary and cost-effective. The PA request must be submitted by a prescribing physician and include detailed clinical documentation, such as lab results (e.g., HbA1c levels for diabetes or BMI for weight loss), a history of failed alternative treatments, and a treatment plan outlining how Zepbound will improve the patient’s condition.

For diabetes, Tricare may require evidence that the patient has tried and failed at least two other diabetes medications. For weight loss, the PA must demonstrate that the beneficiary has participated in a structured weight-loss program for at least six months without success. Tricare’s pharmacy benefit manager (PBM) reviews the request, typically within 7–10 business days, and may approve, deny, or request additional information. If denied, beneficiaries can appeal the decision. Given the complexity of the PA process, working with a healthcare provider familiar with Tricare’s requirements is essential for approval.

How to Get Tricare to Cover Zepbound

To maximize the chances of Tricare covering Zepbound, beneficiaries should follow a strategic approach:

1. Consult a Tricare-Approved Provider: Ensure the prescribing physician is familiar with Tricare’s formulary and prior authorization requirements. Endocrinologists or obesity medicine specialists may have higher success rates in securing approval.

2. Document Medical Necessity: For diabetes, provide lab results showing uncontrolled HbA1c despite other treatments. For weight loss, include records of failed diet/exercise programs and BMI documentation.

3. Submit a Comprehensive PA: The prior authorization should include:

   • A detailed treatment history.
   • Justification for why Zepbound is superior to alternatives.
   • A plan for monitoring progress (e.g., quarterly HbA1c tests or weight checks).

4. Use Tricare’s Preferred Pharmacy Network: Filling Zepbound through Tricare’s mail-order pharmacy or a network retail pharmacy can reduce costs and streamline approval.

5. Appeal if Denied: If the initial request is rejected, beneficiaries can submit an appeal with additional supporting evidence, such as letters from specialists or new clinical data.

Proactive communication with Tricare’s customer service and the prescribing provider can also help navigate the process efficiently.

What to Do If Tricare Denies Zepbound

If Tricare denies coverage for Zepbound, beneficiaries have several options to challenge the decision:

1. Request a Reconsideration: The first step is to submit a reconsideration request within 90 days of the denial. This involves providing additional clinical evidence, such as updated lab results or a letter from the prescribing physician reinforcing the need for Zepbound.

2. File a Formal Appeal: If the reconsideration is denied, beneficiaries can escalate the case to a formal appeal, which is reviewed by an independent Tricare contractor. This process may take 30–60 days and requires a detailed written statement explaining why Zepbound is medically necessary.

3. Seek External Review: For final denials, beneficiaries can request an external review by an independent third party. This is the last level of appeal and is typically reserved for cases where Tricare’s decision is deemed arbitrary or unsupported by medical evidence.

4. Explore Patient Assistance Programs: If appeals fail, Eli Lilly (the manufacturer of Zepbound) offers a savings card that can reduce out-of-pocket costs for eligible patients. Additionally, some non-profit organizations provide financial assistance for weight-loss or diabetes medications.

5. Consider Alternative Treatments: If Zepbound remains inaccessible, beneficiaries can discuss alternative medications (e.g., Wegovy for weight loss or Ozempic for diabetes) with their provider, which may have different coverage criteria.

Tricare Alternatives If Zepbound Is Not Covered

If Tricare denies coverage for Zepbound, beneficiaries can explore alternative treatments and financial assistance options:

1. Other GLP-1 Agonists: Tricare may cover Ozempic (semaglutide) for diabetes or Wegovy (semaglutide) for weight loss, as these medications have similar mechanisms of action but may be listed on Tricare’s formulary at a lower tier.

2. Bariatric Surgery: For weight loss, Tricare covers bariatric surgery (e.g., gastric bypass or sleeve gastrectomy) for beneficiaries with a BMI ≥40 or ≥35 with comorbidities. This may be a more cost-effective long-term solution than Zepbound.

3. Lifestyle Modification Programs: Tricare offers weight-management programs through its Healthy Weights Initiative, which includes nutrition counseling and fitness resources. While not a substitute for Zepbound, these programs can support overall health.

4. Manufacturer Coupons: Eli Lilly’s Zepbound savings card can reduce copays to $25 per month for eligible patients, even if Tricare does not cover the medication. Income-based assistance programs may also be available.

5. Clinical Trials: Some beneficiaries may qualify for clinical trials studying Zepbound or similar medications, which provide access to the drug at no cost.

6. State or Local Assistance Programs: Some states offer pharmaceutical assistance programs for low-income individuals, which may help cover the cost of Zepbound or alternatives.

Frequently Asked Questions

Does Tricare cover Zepbound for weight loss?

Tricare may cover Zepbound for weight loss if the beneficiary has a BMI ≥30 (or ≥27 with comorbidities) and has failed prior weight-loss interventions. Prior authorization is required, and coverage is typically limited to a trial period. Approval is not guaranteed, as Tricare prioritizes lifestyle modifications and bariatric surgery for obesity management.

How much is the Zepbound copay with Tricare?

The copay for Zepbound with Tricare ranges from $20 to $60 per month, depending on the beneficiary’s plan (Prime vs. Select) and formulary tier. Active-duty service members may pay little to no copay, while retirees and dependents under Tricare Select may face higher costs. The exact amount can be verified through Tricare’s pharmacy portal.

Can I appeal if Tricare denies Zepbound?

Yes, beneficiaries can appeal a Tricare denial for Zepbound through a reconsideration request, followed by a formal appeal and an external review if necessary. The process requires additional clinical documentation and may take several weeks. Working with the prescribing provider to strengthen the case can improve the chances of approval.